Trial intelligence / Profile preview

Adherence and Satisfaction of Loceryl vs Urea/Bifonazole in Onychomycosis

NCT02705664Phase 4Completed

Sponsor
Galderma
Start
Jan 2016
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amorolfine in onychomycosis, sponsored by Galderma. Started Jan 2016; status: completed.

02

Drugs

amorolfine
03

Conditions

onychomycosis

Beyond the preview

Go deeper on NCT02705664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02705664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call